吸入式一氧化氮市场规模、份额和成长分析（按产品类型、应用、强度、产品、最终用户和地区）- 产业预测，2025-2032 年

2023 年全球吸入一氧化氮市场规模价值 12 亿美元，预计将从 2024 年的 12.9 亿美元成长到 2032 年的 23.8 亿美元，预测期间（2025-2032 年）的复合年增长率为 7.9%。

一氧化氮是多器官存活和血管健康的必需化学物质，并具有重要的抗菌特性和心臟和脑血管益处。一氧化氮在呼吸治疗中很有价值，因为它可以改善通气灌注匹配并增强动脉氧合。运动员和健身爱好者通常会补充一氧化氮，以促进运动期间的血流量、氧气输送和营养吸收，从而推动市场需求。行业主要企业正致力于优化氮气和氧气等必需气体的运输网络，特别是在製药和医疗保健领域。由于人们对其医疗保健应用的认识不断提高、心血管和呼吸系统疾病发病率的上升以及持续的研究和开发，吸入一氧化氮市场预计会成长。随着医疗相关人员越来越意识到一氧化氮的治疗益处，对吸入一氧化氮的需求预计将飙升。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

吸入式一氧化氮市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 孩子们
• 成人

吸入式一氧化氮市场规模（依产品类型及复合年增长率） (2025-2032)

• 市场概况
• 吸入式一氧化氮输送系统
• 耗材
• 一氧化氮气瓶
• 运输配件
• 其他的

吸入式一氧化氮市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 新生儿呼吸护理
• 慢性阻塞性肺病(COPD)
• 急性呼吸窘迫症候群(ARDS)
• 结核病治疗
• 疟疾治疗
• 其他的

吸入式一氧化氮市场规模（按强度和复合年增长率） (2025-2032)

• 市场概况
• 100ppm
• 800ppm
• 其他的

吸入式一氧化氮市场规模（依产品及复合年增长率） (2025-2032)

• 市场概况
• 一次性的
• 系统

吸入式一氧化氮市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 门诊中心
• 诊所

吸入式一氧化氮市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Mallinckrodt Pharmaceuticals（United States）
• Key Developments
• Air Liquide Healthcare（France）
• VERO Biotech（United States）
• Getinge AB（Sweden）
• Beyond Air, Inc.（United States）
• SLE Ltd.（United Kingdom）
• Bellerophon Therapeutics（United States）
• International Biomedical（United States）
• NIOX Group plc（United Kingdom）
• BOC Healthcare（United Kingdom）
• Merck KGaA（Germany）
• Nu-Med Plus Inc.（United States）
• Perma Pure LLC（United States）
• HALMA PLC（United Kingdom）
• Matheson Tri-Gas Inc.（United States）
• Circassia Pharmaceuticals（United Kingdom）
• International Biomedical（United States）

结论和建议

Global Inhaled Nitric Oxide Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.38 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Nitric oxide serves as a vital chemical for multiorgan survival and vascular health, showcasing significant antibacterial properties and cardio-cerebrovascular advantages. It enhances ventilation-perfusion matching and arterial oxygenation, making it invaluable in respiratory therapies. Athletes and fitness enthusiasts commonly supplement with nitric oxide, benefiting from increased blood flow, oxygen delivery, and nutrient absorption during exercise, driving market demand. Key industry players focus on optimizing transport networks for essential gases like nitrogen and oxygen, particularly within the pharmaceutical and healthcare sectors. The inhaled nitric oxide market is poised for growth, propelled by heightened awareness of its healthcare applications, rising rates of cardiovascular and respiratory conditions, and ongoing research developments. As medical professionals recognize its therapeutic benefits, demand for inhaled nitric oxide is expected to surge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Market Segments Analysis

Global Inhaled Nitric Oxide Market is segmented by Type, Product Type, Application, Strength, Product, End-user and Region. Based on Type, the market is segmented into Pediatric and Adult. Based on Product Type, the market is segmented into Inhaled Nitric Oxide Delivery Systems, Consumables, Nitric Oxide Cylinders, Delivery Accessories and Others. Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment and Others. Based on Strength, the market is segmented into 100 ppm, 800 ppm and Others. Based on Product, the market is segmented into Disposables and System. Based on End-user, the market is segmented into Hospitals, Ambulatory Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is greatly influenced by the increasing incidence of respiratory diseases. As these conditions affect a larger segment of the population worldwide, the demand for inhaled nitric oxide as a therapeutic option is expected to rise correspondingly. Various environmental factors, including air pollution, tobacco smoke, and occupational hazards, contribute significantly to respiratory health issues, heightening the risk of developing respiratory conditions. Additionally, the aging population faces diminished immune responses and natural declines in lung function, making them more susceptible to these illnesses. Consequently, as the global population ages, the prevalence of respiratory disorders is likely to escalate.

Restraints in the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market faces several restraints due to stringent regulatory requirements that products must satisfy. The standardisation and approval processes for pharmaceutical products are both costly and time-consuming, which can hinder market growth and slow the introduction of new therapies. Additionally, pricing and reimbursement strategies present substantial regulatory hurdles in various healthcare systems. Companies must engage in complex negotiations with payers to ensure financial reimbursement for their products, all while successfully navigating the intricate landscape of health technology assessment. These factors collectively pose challenges to market accessibility and innovation within the industry.

Market Trends of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is witnessing a significant upward trend, primarily driven by the rising prevalence of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These conditions, exacerbated by factors like increased smoking and industrialization, pose serious health risks and impair quality of life, thus elevating the need for effective treatments. Inhaled nitric oxide has emerged as a promising therapeutic option for managing these ailments, improving pulmonary function and providing symptomatic relief. As awareness of its benefits spreads and patient populations grow, the market is expected to expand substantially in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Inhaled Nitric Oxide Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Inhaled Nitric Oxide Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhaled Nitric Oxide Delivery Systems
• Consumables
• Nitric Oxide Cylinders
• Delivery Accessories
• Others

Global Inhaled Nitric Oxide Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Tuberculosis Treatment
• Malaria Treatment
• Others

Global Inhaled Nitric Oxide Market Size by Strength & CAGR (2025-2032)

• Market Overview
• 100 ppm
• 800 ppm
• Others

Global Inhaled Nitric Oxide Market Size by Product & CAGR (2025-2032)

• Market Overview
• Disposables
• System

Global Inhaled Nitric Oxide Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Centers
• Clinics

Global Inhaled Nitric Oxide Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Application, Strength, Product, End-user)
  • US
  • Canada
• Europe (Type, Product Type, Application, Strength, Product, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Application, Strength, Product, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Application, Strength, Product, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Application, Strength, Product, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Air Liquide Healthcare (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VERO Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beyond Air, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLE Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIOX Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nu-Med Plus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perma Pure LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HALMA PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matheson Tri-Gas Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circassia Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations